Fig. 4From: Anti-CGRP antibody galcanezumab modifies the function of the trigeminovascular nocisensor complex in the ratRelative changes in histamine release induced by CGRP at 10 μM and 2.5 μg/ml compound 48/80 in control animals (grey) and rats treated with galcanezumab 7 days prior to the experiment (green). The number of experiments is indicated in the bars. *: p < 0.05Back to article page